pCXN2-HA-AT1R-YFP Citations (5)

Originally described in: Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.
Inuzuka T, Fujioka Y, Tsuda M, Fujioka M, Satoh AO, Horiuchi K, Nishide S, Nanbo A, Tanaka S, Ohba Y Sci Rep. 2016 Feb 9;6:21613. doi: 10.1038/srep21613. PubMed Journal

---

Articles Citing pCXN2-HA-AT1R-YFP

Articles
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer. Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA. Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26. PubMed
Cell autonomous angiotensin II signaling controls the pleiotropic functions of oncogenic K-Ras. Volonte D, Sedorovitz M, Cespedes VE, Beecher ML, Galbiati F. J Biol Chem. 2021 Jan-Jun;296:100242. doi: 10.1074/jbc.RA120.015188. Epub 2021 Jan 8. PubMed
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, Zhou R, Chan KH, Zhao H, Zhu L, Siu KL, Fung SY, Yung S, Chan TM, To KK, Chan JF, Cai Z, Lau SKP, Chen Z, Jin DY, Woo PCY, Yuen KY. Cell. 2021 Apr 15;184(8):2212-2228.e12. doi: 10.1016/j.cell.2021.02.053. Epub 2021 Mar 2. PubMed
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties. Sauge E, Pechkovsky D, Atmuri NDP, Tehrani AY, White Z, Dong Y, Cait J, Hughes M, Tam A, Donen G, Yuen C, Walker MJA, McNagny KM, Sin DD, Ciufolini MA, Bernatchez P. Vascul Pharmacol. 2022 Dec;147:107112. doi: 10.1016/j.vph.2022.107112. Epub 2022 Sep 27. PubMed
Effect of the structural modification of Candesartan with Zinc on hypertension and left ventricular hypertrophy. Martinez VR, Martins Lima A, Stergiopulos N, Velez Rueda JO, Islas MS, Griera M, Calleros L, Rodriguez Puyol M, Jaquenod de Giusti C, Portiansky EL, Ferrer EG, De Giusti V, Williams PAM. Eur J Pharmacol. 2023 May 5;946:175654. doi: 10.1016/j.ejphar.2023.175654. Epub 2023 Mar 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.